Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system
Emeli Chatterjee, Rodosthenis S. Rodosthenous, Ville Kujala, Priyanka Gokulnath, Michail Spanos, Helge Immo Lehmann, Getulio Pereira de Oliveira, Mingjian Shi, Tyne W. Miller-Fleming, Guoping Li, Ionita Calin Ghiran, Katia Karalis, JoAnn Lindenfeld, Jonathan D. Mosley, Emily S. Lau, Jennifer E. Ho, Quanhu Sheng, Ravi Shah, Saumya Das
Emeli Chatterjee, Rodosthenis S. Rodosthenous, Ville Kujala, Priyanka Gokulnath, Michail Spanos, Helge Immo Lehmann, Getulio Pereira de Oliveira, Mingjian Shi, Tyne W. Miller-Fleming, Guoping Li, Ionita Calin Ghiran, Katia Karalis, JoAnn Lindenfeld, Jonathan D. Mosley, Emily S. Lau, Jennifer E. Ho, Quanhu Sheng, Ravi Shah, Saumya Das
View: Text | PDF
Clinical Research and Public Health Cardiology Nephrology

Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system

  • Text
  • PDF
Abstract

BACKGROUND Cardiorenal syndrome (CRS) — renal injury during heart failure (HF) — is linked to high morbidity. Whether circulating extracellular vesicles (EVs) and their RNA cargo directly impact its pathogenesis remains unclear.METHODS We investigated the role of circulating EVs from patients with CRS on renal epithelial/endothelial cells using a microfluidic kidney-on-chip (KOC) model. The small RNA cargo of circulating EVs was regressed against serum creatinine to prioritize subsets of functionally relevant EV-miRNAs and their mRNA targets investigated using in silico pathway analysis, human genetics, and interrogation of expression in the KOC model and in renal tissue. The functional effects of EV-RNAs on kidney epithelial cells were experimentally validated.RESULTS Renal epithelial and endothelial cells in the KOC model exhibited uptake of EVs from patients with HF. HF-CRS EVs led to higher expression of renal injury markers (IL18, LCN2, HAVCR1) relative to non-CRS EVs. A total of 15 EV-miRNAs were associated with creatinine, targeting 1,143 gene targets specifying pathways relevant to renal injury, including TGF-β and AMPK signaling. We observed directionally consistent changes in the expression of TGF-β pathway members (BMP6, FST, TIMP3) in the KOC model exposed to CRS EVs, which were validated in epithelial cells treated with corresponding inhibitors and mimics of miRNAs. A similar trend was observed in renal tissue with kidney injury. Mendelian randomization suggested a role for FST in renal function.CONCLUSION Plasma EVs in patients with CRS elicit adverse transcriptional and phenotypic responses in a KOC model by regulating biologically relevant pathways, suggesting a role for EVs in CRS.TRIAL REGISTRATION ClinicalTrials.gov NCT03345446.FUNDING American Heart Association (AHA) (SFRN16SFRN31280008); National Heart, Lung, and Blood Institute (1R35HL150807-01); National Center for Advancing Translational Sciences (UH3 TR002878); and AHA (23CDA1045944)

Authors

Emeli Chatterjee, Rodosthenis S. Rodosthenous, Ville Kujala, Priyanka Gokulnath, Michail Spanos, Helge Immo Lehmann, Getulio Pereira de Oliveira, Mingjian Shi, Tyne W. Miller-Fleming, Guoping Li, Ionita Calin Ghiran, Katia Karalis, JoAnn Lindenfeld, Jonathan D. Mosley, Emily S. Lau, Jennifer E. Ho, Quanhu Sheng, Ravi Shah, Saumya Das

×

Figure 11

MiRNA cocktail 2 mimics the effects the HFpEFCRS on renal epithelial cells.

Options: View larger image (or click on image) Download as PowerPoint
MiRNA cocktail 2 mimics the effects the HFpEFCRS on renal epithelial cel...
(A) Experimental schema of miRNA cocktail 2 comprising mimics of miR-192-5p and miR-21-5p and miRNA inhibitor of 146a-5p designed to mimic the effects of CRS EVs on recipient renal epithelial cells (created with BioRender.com). (B–D) mRNA expression of kidney injury markers (IL18, LCN2, HAVCR1) markedly upregulated in the “Healthy Control EVs+MiRNAs cocktail 2 treated group” compared with “Healthy Controls+Control cocktail 2 treated group.” (E–J) QRT-PCR analyses showed marked downregulation of BMP6, FST, TIMP3, and SMAD7 and marked upregulation of EGFR and SMAD4 in the “Healthy Control+miRNAs cocktail 2 treated group” compared with “Healthy Control+Control cocktail 2 treated group.” GAPDH was used as internal loading control. n = 3 replicates for each group. Results were analyzed by unpaired t test and expressed as ±SEM of 3 independent experiments. *, P < 0.05; **, P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts